human igg expression vector (InvivoGen)
InvivoGen is a verified supplier 
InvivoGen manufactures this product 
93
Structured Review
InvivoGen
human igg expression vector
Human Igg Expression Vector, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+igg+expression+vector/pFUSE-hIgG4-Fc2/pm37097643-250-14-18
Average 93 stars, based on 8 article reviews
Human Igg Expression Vector, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+igg+expression+vector/pFUSE-hIgG4-Fc2/pm37097643-250-14-18
Average 93 stars, based on 8 article reviews
human igg expression vector - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Sequencing:Article Title: A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade. Article Snippet: Cancer immunotherapy have changed the paradigm of cancer treatment, but there remains a great need for improvement given that less patients with tumors respond to the treatment of PD-1/PD-L1 blockade.. TIGIT (also called T cell immunoreceptor with Ig and ITIM domains), a novel immune checkpoint molecule, has been shown a promising target for drug development of immunotherapy.. Here we report generation and characterization of a multivalent bispecific antibody (BsAb) that co-targets PD-L1 and TIGIT. Article Title: High affinity SIRP-alpha reagents and methods of using Article Snippet: .. For expression of SIRPα variant proteins as fusions to human IgG4 and IgG2 Fc chains, SIRPα variants were cloned into Clone Assay:Article Title: A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade. Article Snippet: Cancer immunotherapy have changed the paradigm of cancer treatment, but there remains a great need for improvement given that less patients with tumors respond to the treatment of PD-1/PD-L1 blockade.. TIGIT (also called T cell immunoreceptor with Ig and ITIM domains), a novel immune checkpoint molecule, has been shown a promising target for drug development of immunotherapy.. Here we report generation and characterization of a multivalent bispecific antibody (BsAb) that co-targets PD-L1 and TIGIT. Article Title: High affinity SIRP-alpha reagents and methods of using Article Snippet: .. For expression of SIRPα variant proteins as fusions to human IgG4 and IgG2 Fc chains, SIRPα variants were cloned into Amplification:Article Title: A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade. Article Snippet: Cancer immunotherapy have changed the paradigm of cancer treatment, but there remains a great need for improvement given that less patients with tumors respond to the treatment of PD-1/PD-L1 blockade.. TIGIT (also called T cell immunoreceptor with Ig and ITIM domains), a novel immune checkpoint molecule, has been shown a promising target for drug development of immunotherapy.. Here we report generation and characterization of a multivalent bispecific antibody (BsAb) that co-targets PD-L1 and TIGIT. Plasmid Preparation:Article Title: A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade. Article Snippet: Cancer immunotherapy have changed the paradigm of cancer treatment, but there remains a great need for improvement given that less patients with tumors respond to the treatment of PD-1/PD-L1 blockade.. TIGIT (also called T cell immunoreceptor with Ig and ITIM domains), a novel immune checkpoint molecule, has been shown a promising target for drug development of immunotherapy.. Here we report generation and characterization of a multivalent bispecific antibody (BsAb) that co-targets PD-L1 and TIGIT. other:Article Title: Intracellular Adhesion Molecule-1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8 + T Cells. Article Snippet: Mouse or human ICAM-1 extracellular domain was cloned into a mouse (Invivogen, pfuse-mchg1) or Article Title: Preparation of a camel-canine chimeric antibody against canine B-cell lymphoma. Article Snippet: Anti-cCD20 sdAb served as the primary antibody, while CoraLite 488-conjugated 6×His His-Tag mouse monoclonal antibody (Proteintech Group, Wuhan, China) was the secondary antibody; both dilutions were 1:250, and the samples were incubated at room temperature for 1 h. PBS was added to the control well. Article Title: Preparation of a camel-canine chimeric antibody against canine B-cell lymphoma Article Snippet: Anti-cCD20 sdAb served as the primary antibody, while CoraLite 488-conjugated 6×His His-Tag mouse monoclonal antibody (Proteintech Group, Wuhan, China) was the secondary antibody; both dilutions were 1:250, and the samples were incubated at room temperature for 1 h. PBS was added to the control well. Article Title: Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8 + T Cells Article Snippet: BALB/c or C57BL/6 mice were purchased from Orient Bio (Gapyeong, Gyeonggi, Korea). Expressing:Article Title: High affinity SIRP-alpha reagents and methods of using Article Snippet: .. For expression of SIRPα variant proteins as fusions to human IgG4 and IgG2 Fc chains, SIRPα variants were cloned into Variant Assay:Article Title: High affinity SIRP-alpha reagents and methods of using Article Snippet: .. For expression of SIRPα variant proteins as fusions to human IgG4 and IgG2 Fc chains, SIRPα variants were cloned into |